HRT and fatty liver disease in menopausal women – a pilot study
Treatments studied
Part of Digestive system clinical trials.
This study tests whether starting hormone replacement therapy (HRT) improves liver health in women with menopause and fatty liver disease (MASLD). It aims to understand how HRT might help reduce fat in the liver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older
- You have gone through menopause (no periods for at least a year, or had your ovaries removed)
- You have fatty liver disease (MASLD) but no other liver disease
- You have not used hormone replacement therapy (HRT) in the last 3 months
- You weigh between BMI 18 and 45 – this covers most body sizes
- You are willing to have an MRI scan and receive information about the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a high-intensity exercise program can improve liver function and insulin sensitivity in people with MASLD (a type of fatty liver disease). It may help you if you are looking for a non-drug way to manage your condition.
This trial tests new medicines for adults with fatty liver disease (MASLD) that has already caused some liver scarring. It aims to see if these drugs can help prevent the liver disease from getting worse.
This study looks at whether having an underactive thyroid can affect the build-up of scar tissue in the liver in people with a condition called MASLD (fatty liver disease linked to metabolic problems). If you have both underactive thyroid and fatty liver, this could help us understand your risk for liver damage.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This trial tests a new medication for people with fatty liver disease. It will see if the drug can reduce liver fat and improve liver health over several doses.
This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.
Hear when a new Menopause trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.